US20050010055A1 - N-alkylation of indole derivatives - Google Patents

N-alkylation of indole derivatives Download PDF

Info

Publication number
US20050010055A1
US20050010055A1 US10/917,058 US91705804A US2005010055A1 US 20050010055 A1 US20050010055 A1 US 20050010055A1 US 91705804 A US91705804 A US 91705804A US 2005010055 A1 US2005010055 A1 US 2005010055A1
Authority
US
United States
Prior art keywords
formula
reaction
base
mmol
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/917,058
Inventor
Steven Dell
Mario Lozanov
Wen-Chung Shieh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/917,058 priority Critical patent/US20050010055A1/en
Publication of US20050010055A1 publication Critical patent/US20050010055A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Definitions

  • the present invention provides highly efficient, catalytic methods for N-alkylation of indole derivatives, more specifically the method provides N-methylindole and N-benzyl-indole derivatives.
  • N-Methylindole derivatives such as indole alkaloids
  • indole alkaloids are important natural products that exhibit a wide array of biological activities.
  • affinisine has been shown to produce delayed intention tremors, marked central nervous system (CNS) depressant activity, ataxia, hypothermia and bradypnea (Liu et al., Tetrahedron Lett., 2000, 41, 6299), and a synthetic pentacyclic indole analog has revealed antitumoral properties (Christophe et al., Tetrahedron Lett. 1998, 39, 9431).
  • N-alkylindole derivatives typically require a two-step protocol: (1) formation of an active indole anion by stoichiometric amount of a strong base; and (2) reaction of the resulting anion with a toxic and hazardous alkylating agent such as methyl iodide, dimethyl sulfate, benzyl chloride or benzyl bromide (e.g. Hilton et al., J. Chem. Soc., Chem. Commun. 2001, 209; Tratrat et al., J. Org. Chem. 2000, 65, 6773; and Ottoni et al., Tetrahedron 1998, 54, 13915).
  • a toxic and hazardous alkylating agent such as methyl iodide, dimethyl sulfate, benzyl chloride or benzyl bromide
  • the present invention provides methods for the efficient preparation of indole derivatives of the formula wherein X is methyl (Me) or benzyl (Bn), and R 1 , R 2 , R 3 and R 4 are independently hydrogen, halogen, cyano, nitro, hydroxy, optionally substituted alkyl, alkoxy, aralkoxy, carboxy, alkoxycarbonyl, aryl or heteroaryl; or R 1 and R 2 combined together with the carbon atoms to which they are attached form a fused 6-membered aromatic ring; by reacting indoles of the formula wherein R 1 , R 2 , R 3 and R 4 have meanings as defined for formula I, with dimethyl carbonate (DMC) when X is methyl, or with dibenzyl carbonate (DBC) when X is benzyl, in the presence of a catalytic amount of a base at an ambient temperature to afford compounds of formula I wherein X, R 1 , R 2 , R 3 and R 4 have meaning
  • the present invention provides methylation and benzylation of the indole nitrogen in nearly quantitative yields using 1,4-diazabicyclo[2.2.2]octane (DABCO) as the base in a catalytic amount under mild conditions, wherein the alkylations may be conducted in the absence or the presence of an ionic liquid, under microwave irradiation or utilizing conventional heat, or combinations thereof.
  • DABCO 1,4-diazabicyclo[2.2.2]octane
  • the present invention provides highly efficient, catalytic processes for the manufacture of N-methylindole and N-benzylindole derivatives.
  • optionally substituted alkyl refers to unsubstituted or substituted straight or branched chain hydrocarbon groups having 1 to 20 carbon atoms, preferably 1 to 7 carbon atoms.
  • exemplary unsubstituted alkyl groups include methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl, isobutyl, pentyl, hexyl, isohexyl, heptyl, 4,4-dimethylpentyl, octyl and the like.
  • Substituted alkyl groups include, but are not limited to, alkyl groups substituted by one or more of the following groups: halo, hydroxy, cycloalkyl, alkanoyl, alkoxy, alkanoyloxy, amino, alkylamino, dialkylamino, thiol, alkylthio, alkylthiono, alkylsulfonyl, nitro, cyano, carboxy, alkoxycarbonyl, aryl, alkenyl, alkynyl, aralkoxy and the like.
  • alkenyl refers to any of the above alkyl groups having at least two carbon atoms and further containing a carbon to carbon double bond at the point of attachment. Groups having two to four carbon atoms are preferred.
  • alkynyl refers to any of the above alkyl groups having at least two carbon atoms and further containing a carbon to carbon triple bond double bond at the point of attachment. Groups having two to four carbon atoms are preferred.
  • cycloalkyl refers to optionally substituted monocyclic hydrocarbon groups of 3 to 7 carbon atoms, each of which may be substituted by one or more substituents such as alkyl, halo, oxo, hydroxy, alkoxy, alkylthio, nitro, cyano and the like.
  • Exemplary monocyclic hydrocarbon groups include but are not limited to cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl and cyclohexenyl and the like.
  • halogen refers to fluorine, chlorine, bromine and iodine.
  • alkoxy refers to alkyl-O—.
  • alkanoyl refers to alkyl-C(O)—.
  • alkanoyloxy refers to alkyl-C(O)—O—.
  • alkylamino and “dialkylamino” refer to alkyl-NH— and (alkyl) 2 N—, respectively.
  • alkylthio refers to alkyl-S—.
  • alkylthiono refers to alkyl-S(O)—.
  • alkylsulfonyl refers to alkyl-S(O) 2 —.
  • alkoxycarbonyl refers to alkyl-O—C(O)—.
  • aryl refers to monocyclic or bicyclic aromatic hydrocarbon groups having 6 to 12 carbon atoms in the ring portion, such as phenyl, naphthyl, tetrahydronaphthyl, biphenyl and diphenyl groups, each of which may optionally be substituted by one to four substituents such as alkyl, halo, hydroxy, alkoxy, alkylthio, nitro, cyano and the like.
  • monocyclic aryl refers to optionally substituted phenyl as described under aryl.
  • aralkyl refers to an aryl group bonded directly through an alkyl group, such as benzyl and phenethyl.
  • alkoxy refers to an aryl group bonded directly through an alkoxy group.
  • heteroaryl refers to an aromatic heterocycle, for example monocyclic or bicyclic aryl, such as pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, furyl, thienyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, indolyl, benzothiazolyl, benzoxazolyl, benzothienyl, quinolinyl, isoquinolinyl, benzimidazolyl, benzofuryl, and the like, optionally substituted by e.g. lower alkyl, lower alkoxy or halo.
  • ionic liquid refers to organic salts that are liquid at or close to room temperature. They differ from common salts by having unusually low melting points. Ionic liquids tend to be liquid over a wide temperature range, they may be immiscible with a number of organic solvents as well as water, depending on the anion, and they may be employed as highly polar yet noncoordinating solvents. Furthermore, ionic liquids are nonvolatile and have essentially no vapor pressure. Most are air and water stable. The properties of the ionic liquids can be tailored by varying the cation and anion, the most common are those with alkylammonium, alkylphosphonium, N-alkylpyridinium and N,N-dialkylimidazolium cations.
  • ionic liquids are formed by reacting a tertiary amine or a nitrogen-containing heterocyclic ring, preferably a heteroaromatic ring, with an alkylating agent (e.g. an alkyl halide) to form a quaternary ammonium salt, and performing ion exchange or other suitable reactions with various Lewis acids or their conjugate bases to form ionic liquids.
  • alkylating agent e.g. an alkyl halide
  • suitable tertiary amines and heteroaromatic rings include tri-n-butylamine, trioctylamine, trioctadecylamine, substituted pyridines, optionally substituted imidazoles and pyrroles.
  • alkylating agent e.g. an alkyl halide
  • suitable tertiary amines and heteroaromatic rings include tri-n-butylamine, trioctylamine, trioctadecylamine, substituted pyr
  • Counterions which have been used include chloride, bromide, iodide, chloroaluminate, bromoaluminate, tetrafluoroborate, tetrachloroborate, hexafluoro-phosphate, nitrate, trifluoromethanesulfonate, methylsulfonate, p-toluenesulfonate, hexafluoroantimonate, hexafluoroarsenate, tetrachloroaluminate, tetrabromoaluminate, perchlorate, hydroxide anion, copper dichloride anion, iron trichloride anion, zinc trichloride anion, as well as various lanthanum, potassium, lithium, nickel, cobalt, manganese, and other metal containing anions.
  • Low melting solids may also be used in place of ionic liquids.
  • Low melting solids are generally similar to ionic liquids but have melting points between room temperature and about 80° C., or they are liquids under the reaction conditions.
  • ionic liquids as defined herein above are tetra-n-butylammonium chloride (TBAC), tetra-n-butylammonium triflate (n-Bu 4 N + OTf), tetra-n-butylammonium tetrafluoroborate (n-Bu 4 N + BF 4 ⁇ ), tetra-n-butylammonium hexafluorophosphate (n-Bu 4 N + PF 6 ⁇ ), 1-n-butyl-3-methyl-imidazolium chloride (bmim + Cl ⁇ ), 1-ethyl-3-methylimidazolium chloride (emim + Cl ⁇ ) and 1-n-hexyl-3-methyl-imidazolium chloride (hmim + Cl ⁇ ).
  • TBAC tetra-n-butylammonium chloride
  • n-Bu 4 N + OTf tetra-n-butylammonium triflat
  • microwave irradiation refers to microwave region of the electromagnetic spectrum corresponding to wavelengths from 1 cm to 1 m and to frequencies from 300 MHz to 30 GHz.
  • domestic and industrial microwave ovens generally operate at greater than 900 MHz, preferably from about 2450 MHz to about 2455 MHz, in order to prevent interference with RADAR transmissions and telecommunications.
  • Sources of microwave irradiation include multimode ovens and monomode ovens which may be batch or continuous devices.
  • a preferred monomode oven is a continuous-flow reactor, such as a Milestone ETHOS—CFR continuous-flow reactor.
  • the methods of the present invention provides efficient catalytic processes for the preparation indole derivatives of the formula wherein X is methyl or benzyl, and R 1 , R 2 , R 3 and R 4 are independently hydrogen, halogen, cyano, nitro, hydroxy, optionally substituted alkyl, alkoxy, aralkoxy, carboxy, alkoxycarbonyl, aryl or heteroaryl; or R 1 and R 2 combined together with the carbon atoms to which they are attached form a fused 6-membered aromatic ring; by reacting indoles of the formula wherein R 1 , R 2 , R 3 and R 4 have meanings as defined for formula 1, with DMC when X is methyl, or with DBC when X is benzyl, in the presence of a catalytic amount of a base, preferably DABCO, at an ambient temperature, preferably at a temperature ranging from about 80° C.
  • a catalytic amount of a base preferably DABCO
  • N-methylation reactions are carried out at a temperature ranging from about 90° C. to about 95° C., and N-benzylation reactions at a temperature of about 135° C.
  • the reaction time may range from about 1 h to about 36 h for N-methylation, and from about 1 h to about 100 h for N-benzylation.
  • alkylation of the indole nitrogen of compounds of formula II, wherein R 1 , R 2 , R 3 and R 4 have meanings as defined herein above may be conducted in the presence or the absence of an organic solvent such as toluene, acetonitrile, N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMA) or N-methylpyrrolidinone (NMP), preferably DMF or DMA.
  • an organic solvent such as toluene, acetonitrile, N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMA) or N-methylpyrrolidinone (NMP), preferably DMF or DMA.
  • the alkylation reactions of the present invention may be carried out in the presence of an ionic liquid, preferably, TBAC.
  • the ionic liquid may be employed as the reaction solvent, or it may be used as an additive when the alkylations are conducted in an organic solvent, such as those described herein above, to enhance the reaction rates.
  • the alkylations, in particular, the N-benzylation reactions are carried out in DMA in the presence of about one molar equivalent (equiv) of an ionic liquid.
  • microwave irradiation may be employed to enhance the rates of the alkylation reactions of the present invention.
  • the alkylation reactions may be conducted under microwave irradiation at a frequency ranging from 300 MHz to 30 GHz generating a reaction temperature which ranges from about 120° C. to about 300° C., preferably, from about 140° C. to about 250° C. Most preferably, the alkylations are conducted at a temperature of about 160° C.
  • the alkylations are carried out for a period of microwave irradiation time ranging from about 1 second to about 300 min, more preferably from about 5 min to about 30 min.
  • the microwave alkylations are conducted under a pressure ranging from about 1 bar to about 60 bar, preferably, from about 10 bar to about 35 bar, most preferably about 20 bar.
  • the N-alkylation of indoles of formula II, wherein R 1 , R 2 , R 3 and R 4 have meanings as defined herein above, is carried out in a molar concentration (M) of the substrate ranging from 0.1 M to 1.0 M.
  • M molar concentration
  • the molar ratio of the base to the substrate of formula II initially present in the reaction mixture ranges preferably from 0.01:1 to 0.5:1. More preferably, the molar ratio ranges from 0.05:1 to 0.15:1 for N-methylation reactions, and from 0.05:1 to 0.35:1 for N-benzylation reactions.
  • N-methylation using 0.1 equiv of N,N-dimethylamino-pyridine (DMAP) or 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) affords the methylcarbamate of formula III (X is methyl, entries 3 and 4) as the major component of the reaction mixture. It should be noted that without any base catalyst or in the presence of tri-n-butylamine (n-Bu 3 N), the N-methylation generates no product at all (entries 1 and 2).
  • the catalytic process of the present invention provides N-benzylindole of formula Ia (X is benzyl, entries 7 and 9) in good yield in the presence of only 0.1 equiv of DABCO.
  • X is benzyl, entries 7 and 9
  • the N-benzylation reactions are generally slower than the corresponding N-methylations and require higher reaction temperatures and longer reaction times under the reaction conditions employed herein.
  • indole of formula IIb i.e., carbazole
  • N-benzlindole of formula Ib may be converted to N-benzlindole of formula Ib within 3 h in excellent yield in the presence of one equiv of TBAC (entry 9).
  • the imidazolium-series of ionic liquids are less effective, and ionic liquids that contain a chloride anion consistently perform better than the ones containing a different counterion (entries 5 and 7 to 9).
  • TABLE 2 The effect of ionic liquids on the benzylation rate of carbazole.
  • protecting groups may be required to introduce protecting groups to protect other functional groups from undesired reactions with the reaction components under the conditions used for carrying out the N-alkylation of the indole nitrogen of compounds of formula II.
  • the need and choice of protecting groups for a particular reaction is known to those skilled in the art and depends on the nature of the functional group to be protected, the structure and stability of the molecule of which the substituent is a part and the reaction conditions.
  • a mixture of 5-bromoindole (3.92 g, 20 mmol), DBC (14.52 g, 60 mmol), DABCO (224 mg, 2.0 mmol) and TBAC (5.56 g, 20 mmol) is dissolved in CH 3 CN (80 mL).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)

Abstract

The present invention provides methods for the efficient preparation of indole derivatives of the formula
Figure US20050010055A1-20050113-C00001

wherein X is methyl or benzyl; and R1, R2, R3 and R4 are independently hydrogen, halogen, cyano, nitro, hydroxy, optionally substituted alkyl, alkoxy, aralkoxy, carboxy, alkoxycarbonyl, aryl or heteroaryl; or R1 and R2 combined together with the carbon atoms to which they are attached form a fused 6-membered aromatic ring; by reacting indoles of the formula
Figure US20050010055A1-20050113-C00002

wherein R1, R2, R3 and R4 have meanings as defined for formula I, with dimethyl carbonate when X is methyl, or with dibenzyl carbonate when X is benzyl, in the presence of a catalytic amount of a base at an ambient temperature to afford compounds of formula I wherein X, R1, R2, R3 and R4 have meanings as defined herein above. In particular, the present invention provides methylation and benzylation of the indole nitrogen in nearly quantitative yields using 1,4-diazabicyclo[2.2.2]octane as the base in a catalytic amount under mild conditions, wherein the alkylations may be conducted in the absence or the presence of an ionic liquid, under microwave irradiation or utilizing conventional heat, or combinations thereof.

Description

  • This application is a divisional of application Ser. No. 10/620,625, filed Jul. 16, 2003, which claims the benefit of U.S. Provisional Application No. 60/396,827, filed Jul. 18, 2002.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention provides highly efficient, catalytic methods for N-alkylation of indole derivatives, more specifically the method provides N-methylindole and N-benzyl-indole derivatives.
  • 2. Description of Related Art
  • N-Methylindole derivatives, such as indole alkaloids, are important natural products that exhibit a wide array of biological activities. For example, affinisine has been shown to produce delayed intention tremors, marked central nervous system (CNS) depressant activity, ataxia, hypothermia and bradypnea (Liu et al., Tetrahedron Lett., 2000, 41, 6299), and a synthetic pentacyclic indole analog has revealed antitumoral properties (Christophe et al., Tetrahedron Lett. 1998, 39, 9431).
  • Common approaches to the synthesis of N-alkylindole derivatives typically require a two-step protocol: (1) formation of an active indole anion by stoichiometric amount of a strong base; and (2) reaction of the resulting anion with a toxic and hazardous alkylating agent such as methyl iodide, dimethyl sulfate, benzyl chloride or benzyl bromide (e.g. Hilton et al., J. Chem. Soc., Chem. Commun. 2001, 209; Tratrat et al., J. Org. Chem. 2000, 65, 6773; and Ottoni et al., Tetrahedron 1998, 54, 13915). Improved processes have been recently published utilizing non-toxic reagents, however, under harsh and stoichiometric conditions (Bergman et al., Tetrahedron 1990, 46, 6113). It has been reported that dimethyl carbonate may be employed effectively under milder conditions to N-methylate indole derivatives, however, these methods still demand the use of a stoichiometric amount of a base to achieve reasonable process efficiency (Shieh et al., Organic Lett. 2001, 3, 4279; and PCT Application No. WO 01/81305). Thus, development of an efficient, safe, and ecologically friendly methods for alkylation of indoles still constitutes an important challenge.
  • SUMMARY OF THE INVENTION
  • The present invention provides methods for the efficient preparation of indole derivatives of the formula
    Figure US20050010055A1-20050113-C00003

    wherein X is methyl (Me) or benzyl (Bn), and R1, R2, R3 and R4 are independently hydrogen, halogen, cyano, nitro, hydroxy, optionally substituted alkyl, alkoxy, aralkoxy, carboxy, alkoxycarbonyl, aryl or heteroaryl; or R1 and R2 combined together with the carbon atoms to which they are attached form a fused 6-membered aromatic ring; by reacting indoles of the formula
    Figure US20050010055A1-20050113-C00004

    wherein R1, R2, R3 and R4 have meanings as defined for formula I, with dimethyl carbonate (DMC) when X is methyl, or with dibenzyl carbonate (DBC) when X is benzyl, in the presence of a catalytic amount of a base at an ambient temperature to afford compounds of formula I wherein X, R1, R2, R3 and R4 have meanings as defined herein above.
  • In particular, the present invention provides methylation and benzylation of the indole nitrogen in nearly quantitative yields using 1,4-diazabicyclo[2.2.2]octane (DABCO) as the base in a catalytic amount under mild conditions, wherein the alkylations may be conducted in the absence or the presence of an ionic liquid, under microwave irradiation or utilizing conventional heat, or combinations thereof.
  • Other objects, features, advantages and aspects of the present invention will become apparent to those skilled in the art from the following description and appended claims. It should be understood, however, that the following description, appended claims, and specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only. Various changes and modifications within the spirit and scope of the disclosed invention will become readily apparent to those skilled in the art from reading the following.
  • DETAILED DESCRIPTION OF THE INVENTION
  • As described above, the present invention provides highly efficient, catalytic processes for the manufacture of N-methylindole and N-benzylindole derivatives.
  • Listed below are definitions of various terms used to describe the compounds of the instant invention. These definitions apply to the terms as they are used throughout the specification unless they are otherwise limited in specific instances either individually or as part of a larger group.
  • The term “optionally substituted alkyl” refers to unsubstituted or substituted straight or branched chain hydrocarbon groups having 1 to 20 carbon atoms, preferably 1 to 7 carbon atoms. Exemplary unsubstituted alkyl groups include methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl, isobutyl, pentyl, hexyl, isohexyl, heptyl, 4,4-dimethylpentyl, octyl and the like. Substituted alkyl groups include, but are not limited to, alkyl groups substituted by one or more of the following groups: halo, hydroxy, cycloalkyl, alkanoyl, alkoxy, alkanoyloxy, amino, alkylamino, dialkylamino, thiol, alkylthio, alkylthiono, alkylsulfonyl, nitro, cyano, carboxy, alkoxycarbonyl, aryl, alkenyl, alkynyl, aralkoxy and the like.
  • The term “alkenyl” refers to any of the above alkyl groups having at least two carbon atoms and further containing a carbon to carbon double bond at the point of attachment. Groups having two to four carbon atoms are preferred.
  • The term “alkynyl” refers to any of the above alkyl groups having at least two carbon atoms and further containing a carbon to carbon triple bond double bond at the point of attachment. Groups having two to four carbon atoms are preferred.
  • The term “cycloalkyl” refers to optionally substituted monocyclic hydrocarbon groups of 3 to 7 carbon atoms, each of which may be substituted by one or more substituents such as alkyl, halo, oxo, hydroxy, alkoxy, alkylthio, nitro, cyano and the like.
  • Exemplary monocyclic hydrocarbon groups include but are not limited to cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl and cyclohexenyl and the like.
  • The term “halogen” or “halo” refers to fluorine, chlorine, bromine and iodine.
  • The term “alkoxy” refers to alkyl-O—.
  • The term “alkanoyl” refers to alkyl-C(O)—.
  • The term “alkanoyloxy” refers to alkyl-C(O)—O—.
  • The terms “alkylamino” and “dialkylamino” refer to alkyl-NH— and (alkyl)2N—, respectively.
  • The term “alkylthio” refers to alkyl-S—.
  • The term “alkylthiono” refers to alkyl-S(O)—.
  • The term “alkylsulfonyl” refers to alkyl-S(O)2—.
  • The term “alkoxycarbonyl” refers to alkyl-O—C(O)—.
  • The term “aryl” refers to monocyclic or bicyclic aromatic hydrocarbon groups having 6 to 12 carbon atoms in the ring portion, such as phenyl, naphthyl, tetrahydronaphthyl, biphenyl and diphenyl groups, each of which may optionally be substituted by one to four substituents such as alkyl, halo, hydroxy, alkoxy, alkylthio, nitro, cyano and the like.
  • The term “monocyclic aryl” refers to optionally substituted phenyl as described under aryl.
  • The term “aralkyl” refers to an aryl group bonded directly through an alkyl group, such as benzyl and phenethyl.
  • The term “aralkoxy” refers to an aryl group bonded directly through an alkoxy group.
  • The term “heteroaryl” refers to an aromatic heterocycle, for example monocyclic or bicyclic aryl, such as pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, furyl, thienyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, indolyl, benzothiazolyl, benzoxazolyl, benzothienyl, quinolinyl, isoquinolinyl, benzimidazolyl, benzofuryl, and the like, optionally substituted by e.g. lower alkyl, lower alkoxy or halo.
  • The term “ionic liquid” refers to organic salts that are liquid at or close to room temperature. They differ from common salts by having unusually low melting points. Ionic liquids tend to be liquid over a wide temperature range, they may be immiscible with a number of organic solvents as well as water, depending on the anion, and they may be employed as highly polar yet noncoordinating solvents. Furthermore, ionic liquids are nonvolatile and have essentially no vapor pressure. Most are air and water stable. The properties of the ionic liquids can be tailored by varying the cation and anion, the most common are those with alkylammonium, alkylphosphonium, N-alkylpyridinium and N,N-dialkylimidazolium cations.
  • Many ionic liquids are formed by reacting a tertiary amine or a nitrogen-containing heterocyclic ring, preferably a heteroaromatic ring, with an alkylating agent (e.g. an alkyl halide) to form a quaternary ammonium salt, and performing ion exchange or other suitable reactions with various Lewis acids or their conjugate bases to form ionic liquids. Examples of suitable tertiary amines and heteroaromatic rings include tri-n-butylamine, trioctylamine, trioctadecylamine, substituted pyridines, optionally substituted imidazoles and pyrroles. These compounds may be alkylated with virtually any straight, branched or cyclic C1-20 alkyl group, but preferably, the alkyl groups are C1-16 groups, since groups larger than this tend to produce low melting solids rather than ionic liquids.
  • Counterions which have been used include chloride, bromide, iodide, chloroaluminate, bromoaluminate, tetrafluoroborate, tetrachloroborate, hexafluoro-phosphate, nitrate, trifluoromethanesulfonate, methylsulfonate, p-toluenesulfonate, hexafluoroantimonate, hexafluoroarsenate, tetrachloroaluminate, tetrabromoaluminate, perchlorate, hydroxide anion, copper dichloride anion, iron trichloride anion, zinc trichloride anion, as well as various lanthanum, potassium, lithium, nickel, cobalt, manganese, and other metal containing anions.
  • Certain low melting solids may also be used in place of ionic liquids. Low melting solids are generally similar to ionic liquids but have melting points between room temperature and about 80° C., or they are liquids under the reaction conditions.
  • Examples of ionic liquids as defined herein above are tetra-n-butylammonium chloride (TBAC), tetra-n-butylammonium triflate (n-Bu4N+OTf), tetra-n-butylammonium tetrafluoroborate (n-Bu4N+BF4 ), tetra-n-butylammonium hexafluorophosphate (n-Bu4N+PF6−), 1-n-butyl-3-methyl-imidazolium chloride (bmim+Cl), 1-ethyl-3-methylimidazolium chloride (emim+Cl) and 1-n-hexyl-3-methyl-imidazolium chloride (hmim+Cl). Further examples of ionic liquids are described, e.g., in J. Chem. Tech. Biotechnol., 1997, 68, 351; Chem. Ind., 1996, 68, 249; J. Phys. Condensed Matter, 1993, 5 (supp 34B), B99; J. Mater. Chem., 1998, 8, 2627; and Chem. Rev., 1999, 99, 2071.
  • The term “microwave irradiation” as used herein refers to microwave region of the electromagnetic spectrum corresponding to wavelengths from 1 cm to 1 m and to frequencies from 300 MHz to 30 GHz. By International Convention, however, domestic and industrial microwave ovens generally operate at greater than 900 MHz, preferably from about 2450 MHz to about 2455 MHz, in order to prevent interference with RADAR transmissions and telecommunications. Thus, the entire microwave region is not readily available for heating applications. Sources of microwave irradiation include multimode ovens and monomode ovens which may be batch or continuous devices. A preferred monomode oven is a continuous-flow reactor, such as a Milestone ETHOS—CFR continuous-flow reactor.
  • The methods of the present invention provides efficient catalytic processes for the preparation indole derivatives of the formula
    Figure US20050010055A1-20050113-C00005

    wherein X is methyl or benzyl, and R1, R2, R3 and R4 are independently hydrogen, halogen, cyano, nitro, hydroxy, optionally substituted alkyl, alkoxy, aralkoxy, carboxy, alkoxycarbonyl, aryl or heteroaryl; or R1 and R2 combined together with the carbon atoms to which they are attached form a fused 6-membered aromatic ring; by reacting indoles of the formula
    Figure US20050010055A1-20050113-C00006

    wherein R1, R2, R3 and R4 have meanings as defined for formula 1, with DMC when X is methyl, or with DBC when X is benzyl, in the presence of a catalytic amount of a base, preferably DABCO, at an ambient temperature, preferably at a temperature ranging from about 80° C. to about 100° C. for N-methylation reactions, and from about 90° C. to about 150° C. for N-benzylation reactions, to afford compounds of formula I wherein X, R1, R2, R3 and R4 have meanings as defined herein above. More preferably, N-methylation reactions are carried out at a temperature ranging from about 90° C. to about 95° C., and N-benzylation reactions at a temperature of about 135° C. The reaction time may range from about 1 h to about 36 h for N-methylation, and from about 1 h to about 100 h for N-benzylation.
  • According to the methods of the present invention, alkylation of the indole nitrogen of compounds of formula II, wherein R1, R2, R3 and R4 have meanings as defined herein above, may be conducted in the presence or the absence of an organic solvent such as toluene, acetonitrile, N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMA) or N-methylpyrrolidinone (NMP), preferably DMF or DMA.
  • Alternatively, the alkylation reactions of the present invention may be carried out in the presence of an ionic liquid, preferably, TBAC. The ionic liquid may be employed as the reaction solvent, or it may be used as an additive when the alkylations are conducted in an organic solvent, such as those described herein above, to enhance the reaction rates. Preferably, the alkylations, in particular, the N-benzylation reactions are carried out in DMA in the presence of about one molar equivalent (equiv) of an ionic liquid.
  • In addition, microwave irradiation may be employed to enhance the rates of the alkylation reactions of the present invention. The alkylation reactions may be conducted under microwave irradiation at a frequency ranging from 300 MHz to 30 GHz generating a reaction temperature which ranges from about 120° C. to about 300° C., preferably, from about 140° C. to about 250° C. Most preferably, the alkylations are conducted at a temperature of about 160° C. Preferably, the alkylations are carried out for a period of microwave irradiation time ranging from about 1 second to about 300 min, more preferably from about 5 min to about 30 min. When the alkylations are carried out at a temperature greater than the boiling point of any of the components of the reaction mixture it may be advantageous to apply higher pressure in order to prevent boiling of either the reactants or the solvent. Generally, the microwave alkylations are conducted under a pressure ranging from about 1 bar to about 60 bar, preferably, from about 10 bar to about 35 bar, most preferably about 20 bar.
  • Preferably, the N-alkylation of indoles of formula II, wherein R1, R2, R3 and R4 have meanings as defined herein above, is carried out in a molar concentration (M) of the substrate ranging from 0.1 M to 1.0 M.
  • The molar ratio of the base to the substrate of formula II initially present in the reaction mixture ranges preferably from 0.01:1 to 0.5:1. More preferably, the molar ratio ranges from 0.05:1 to 0.15:1 for N-methylation reactions, and from 0.05:1 to 0.35:1 for N-benzylation reactions.
  • The effectiveness of DABCO as the base in the catalytic alkylation of the indole nitrogen of compounds of formula II, wherein R1, R2, R3 and R4 have meanings as defined herein above, using DMC or DBC as the alkylating agent under mild reaction conditions may be demonstrated with 5-bromoindole of formula IIa. As illustrated in the Table 1 below, in the presence of 0.1 equiv (10 mol %) of DABCO, the catalytic process described herein above affords N-methylindole of formula Ia (X is methyl, entry 5) quantitatively within 5 h when heated at 90° C.
    TABLE 1
    N-Alkylation of 5-bromoindole.a
    Figure US20050010055A1-20050113-C00007
    Figure US20050010055A1-20050113-C00008
    Entry X Time (h) Base % of IIa % of Ia % of III
    1b Me 5 None 100 0 0
    2b Me 5 n-Bu3N 100 0 0
    3b Me 5 DMAP 14 12 73
    4b Me 5 DBU 9 6 84
    5b Me 5 DABCO 0 >99 0
    6c Bn 96 None 84 5 11
    7c Bn 96 DABCO 20 80 0
    8d Bn 24 None 53 43 4
    9d Bn 24 DABCO 12 82 6

    aAll reactions are conducted using 0.1 equiv of the base if not otherwise indicated. The compound distributions are determined by HPLC analysis of the reaction mixture. The identity of the components is confirmed by 1H NMR, 13C NMR and MS.

    bThe reaction is conducted on 5 mmol scale in 1 mL of DMF and 10 mL of DMC at 90° C.

    cThe reaction is conducted on 2 mmol scale in 4 mL of DMA and 3 mmol of DBC at 95° C.

    dThe reaction is conducted on 2 mmol scale in 4 mL of DMA and 3 mmol of DBC at 135° C.
  • In contrast thereto, the N-methylation using 0.1 equiv of N,N-dimethylamino-pyridine (DMAP) or 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) affords the methylcarbamate of formula III (X is methyl, entries 3 and 4) as the major component of the reaction mixture. It should be noted that without any base catalyst or in the presence of tri-n-butylamine (n-Bu3N), the N-methylation generates no product at all (entries 1 and 2). Similarly, the catalytic process of the present invention provides N-benzylindole of formula Ia (X is benzyl, entries 7 and 9) in good yield in the presence of only 0.1 equiv of DABCO. As the data in Table 1 illustrate, the N-benzylation reactions are generally slower than the corresponding N-methylations and require higher reaction temperatures and longer reaction times under the reaction conditions employed herein.
  • The effect of a variety of ionic liquids on the reaction rates of N-alkylation reactions of the present invention may be demonstrated with N-benzylation of indole derivative of formula IIb. As shown in Table 2, indole of formula IIb, i.e., carbazole, may be converted to N-benzlindole of formula Ib within 3 h in excellent yield in the presence of one equiv of TBAC (entry 9). In comparison, the imidazolium-series of ionic liquids are less effective, and ionic liquids that contain a chloride anion consistently perform better than the ones containing a different counterion (entries 5 and 7 to 9).
    TABLE 2
    The effect of ionic liquids on the benzylation rate of carbazole.a
    Figure US20050010055A1-20050113-C00009
    Figure US20050010055A1-20050113-C00010
    Entry Ionic Liquid % of Ibb
    1 Nonec 59
    2 bmim+OTf 28
    3 bmim+BF4 34
    4 bmim+PF6 28
    5 bmim+Cl 65
    6 emim+BF4 28
    7 emim+Cl 66
    8 hmim+Cl 79
    9 TBAC 93

    aAlI reactions, except entry 1, are conducted with 2 mmol of IIb, 3 mmol of DBC, 0.6 mmol of DABCO, and 2 mmol of an ionic liquid in 4 mL of DMA at 135° C. for 3 h.

    bThe yields are determined by HPLC analysis of the reaction mixture at the end of the reaction time indicated.

    cSame as procedure a, except no ionic liquid is present.
  • The effect of an ionic liquid on the reaction rates of N-benzylation reactions according to the present invention is further illustrated in Table 3. In a typical experiment, a substrate (2 mmol), i.e., an indole of formula II, DABCO (10-30 mol %), DBC (3 mmol), TBAC (2 mmol) in DMA (4 mL) are heated at 135° C. and the reaction is monitored by HPLC until a trace or no starting material is detected. As promoted by TBAC, the benzylation rates for 5-bromoindole (IIa), carbazole (IIb) and the unsubstituted indole (IIc) are significantly improved as shown by impressive reductions in reaction times to 0.5 h (entry 1), 3 h (entry 2) and 2 h (entry 3), respectively. In the absence of TBAC, the same reactions take 24 h, 72 h and 45 h under otherwise identical reaction conditions.
    TABLE 3
    Reduction of reaction times of N-benzylation in the presence of n-Bu4N+Cl−a.
    Thermalb Ionic Liquidd Microwaveg
    Entry Substrate Producta (time, yield)c (time, yield)c (time, yield)c
    1e IIa
    Figure US20050010055A1-20050113-C00011
    24 h, 79% 0.5 h, 83% 6 min, 76%
    2f IIb
    Figure US20050010055A1-20050113-C00012
    72 h, 80% 3 h, 89% 18 min, 82%
    3f IIc
    Figure US20050010055A1-20050113-C00013
    45 h, 82% 2 h, 80% 12 min, 70%

    aThe identity of the benzylated products is confirmed by 1H and 13C NMR and MS.

    bGeneral procedure using conventional thermal heating: a reaction flask is charged with the substrate (2 mmol), DABCO (10-30 mol %), DMA (4 mL), and DBC (3 mmol). The mixture is heated at 135° C., and the reaction is monitored by HPLC until trace or no starting substrate is detected (reaction time).

    cIsolated yield based on starting substrate.

    dSame as procedure b, except 1 equiv of TBAC is added to the reaction mixture.

    e10 mol % of DABCO.

    f30 mol % of DABCO.

    gGeneral procedure using microwave heating: A solution of the substrate (20 mmol), DBC (60 mmol), DABCO (10-30 mol %), TBAC (20 mmol) in CH3CN (80 mL) is passed through a Milestone ETHOS-CER continuous-flow reactor preheated to 160° C. at 20 bar. The reaction products are analyzed by HPLC after each pass (6 min).
  • It may be required to introduce protecting groups to protect other functional groups from undesired reactions with the reaction components under the conditions used for carrying out the N-alkylation of the indole nitrogen of compounds of formula II. The need and choice of protecting groups for a particular reaction is known to those skilled in the art and depends on the nature of the functional group to be protected, the structure and stability of the molecule of which the substituent is a part and the reaction conditions.
  • Well known protecting groups that meet these conditions and their introduction and removal are described, for example, in McOmie, “Protective Groups in Organic Chemistry”, Plenum Press, London, N.Y., 1973; and Greene and Wuts, “Protective Groups in Organic Synthesis”, John Wiley and Sons, Inc., NY, 1999.
  • The following Examples are intended to illustrate the invention and are not to be construed as being limitations thereon. If not mentioned otherwise, the processes described herein above are conducted under inert atmosphere, preferably under nitrogen atmosphere. All evaporations are performed under reduced pressure, preferably between about 5 and 100 mmHg. The structure of products and starting materials is confirmed by standard analytical methods, e.g. melting points (mp) and spectroscopic characteristics (e.g. MS, NMR). Abbreviations used are those conventional in the art.
  • EXAMPLE 1
  • 5-Bromo-1-methylindole
    Figure US20050010055A1-20050113-C00014
  • To a solution of 5-bromoindole (1.0 g, 5.10 mmol) in DMC (10 mL), DABCO (0.057 g, 0.51 mmol) is added followed by DMF (1 mL). The resulting solution is heated to 90-95° C. for 5 h. The reaction is cooled to RT, and diluted with ethyl acetate (EtOAc, 50 mL) and H2O (50 mL). The organic layer is separated and washed in sequence with H2O (50 mL), 10% aqueous citric acid (2×50 mL) and H2O (4×50 mL). The organic layer is dried over anhydrous sodium sulfate (Na2SO4), filtered and concentrated under vacuum to give 5-bromo-1-methylindole (about 1.06 g, 99%) as a golden colored solid: 1H NMR (CDCl3) δ 7.72 (d, 1H), 7.26 (dd, 1H), 7.13 (d, 1H), 7.00 (d, 1H), 6.39 (d, 1H), 3.71 (s, 3H); 13C NMR (CDCl3) 6135.3, 130.1, 129.9, 124.2, 123.2, 112.6, 110.6, 100.5, 32.9; MS m/z209 [M+1]+.
  • EXAMPLE 2
  • 5-Methoxy-1-methylindole
    Figure US20050010055A1-20050113-C00015
  • To a solution of 5-methoxyindole (1.0 g, 6.79 mmol) in DMC (10 mL), DABCO (0.076 g, 0.68 mmol) is added followed by DMF (2 mL). The resulting solution is heated to 90-95° C. for 7 h. The reaction is cooled to RT, and diluted with EtOAc (40 mL) and H2O (40 mL). The organic layer is separated and washed in sequence with H2O (50 mL), 10% aqueous citric acid (2×40 mL) and H2O (4×40 mL). The organic layer is dried over anhydrous Na2SO4, filtered and concentrated under vacuum to give 5-methoxy-1-methylindole (about 1.06 g, 97%) as a solid: 1H NMR (CDCl3) δ 7.21 (d, 1H), 7.09 (d, 1H), 7.00 (d, 1H), 6.87 (dd, 1H) 6.39 (d, 1H), 3.84 (s, 3H), 3.73 (s, 3H); 13C NMR (CDCl3) 6153.9, 132.1, 129.3, 128.7, 111.8, 109.9, 102.4, 100.3, 55.9, 32.9; MS m/z 161 [M+1]+.
  • EXAMPLE 3
  • 3-Cyano-1-methylindole
    Figure US20050010055A1-20050113-C00016
  • To a solution of 3-cyanoindole (1.0 g, 7.03 mmol) in DMC (10 mL), DABCO (0.079 g, 0.70 mmol) is added and the resulting solution is heated to reflux for 8 h. The reaction is cooled to RT, and diluted with EtOAc (40 mL) and H2O (40 mL). The organic layer is separated and washed in sequence with H2O (50 mL), 10% aqueous citric acid (2×40 mL) and H2O (4×40 mL). The organic layer is dried over anhydrous Na2SO4, filtered and concentrated under vacuum to give 3-cyano-1-methylindole (about 1.08 g, 98%) as an oil: 1H NMR (CDCl3) δ 7.74 (d, 1H), 7.53 (s, 1H), 7.40-7.28 (m, 3H), 3.83 (s, 3H); 13C NMR (CDCl3) 136.0, 135.6, 127.8, 123.8, 122.1, 119.8, 116.0, 110.4, 85.4, 33.6; MS m/z 156 [M+1]+.
  • EXAMPLE 4
  • 1-Methylindole-2-carboxylate
    Figure US20050010055A1-20050113-C00017
  • To a solution of indole-2-carboxylic acid (1.0 g, 6.21 mmol) in DMC (10 mL), DABCO (0.77 g, 6.83 mmol) is added followed by DMF (4 mL) and the resulting solution is heated to 90-95° C. for 21 h. The reaction is cooled to RT, and diluted with EtOAc (50 mL) and H2O (40 mL). The organic layer is separated and washed in sequence with H2O (50 mL), 10% aqueous citric acid (2×40 mL), saturated agueous sodium bicarbonate (NaHCO3, 2×40 mL) and H2O (2×40 mL). The organic layer is dried over anhydrous Na2SO4, filtered and concentrated under vacuum to give 1-methylindole-2-carboxylate (about 1.12 g, 95%) as a solid: 1H NMR (CDCl3) δ 7.68 (d, 1H), 7.37-7.29 (m, 3H), 7.15 (app dt, 1H), 4.07 (s, 3H), 3.91 (s, 3H); 13C NMR (CDCl3) δ 162.6, 139.6, 127.6, 125.8, 125.0, 122.6, 120.5, 110.2, 110.22, 110.18, 51.6, 31.64; MS m/z 189 [M+1]+.
  • EXAMPLE 5
  • 9-Methylcarbazole
    Figure US20050010055A1-20050113-C00018
  • To a solution of carbazole (1.03 g, 6.16 mmol) in DMC (10 mL), DABCO (0.069 g, 0.62 mmol) is added and the resulting solution is heated to 90-95° C. for 24 h. The reaction is cooled to RT, and diluted with EtOAc (40 mL) and H2O (40 mL). The organic layer is separated and washed in sequence with H2O (50 mL), 10% aqueous citric acid (2×40 mL) and H2O (3×40 mL). The organic layer is dried over anhydrous Na2SO4, filtered and concentrated under vacuum to give 9-methylcarbazole (about 1.08 g, 97%) as a beige solid: 1H NMR (CDCl3) δ 8.06 (d, 2H), 7.43 (t, 2H), 7.31 (d, 2H), 7.20 (t, 2H), 3.71 (s, 3H); 13C NMR (CDCl3) 6141.0, 125.7, 122.8, 120.3, 118.9, 108.5, 29.0; MS m/z 181 [M+1]+.
  • EXAMPLE 6
  • 1-Methylindole
    Figure US20050010055A1-20050113-C00019
  • The title compound is prepared analogously to the previous Examples in about 97% yield: 1H NMR (CDCl3) δ 7.62 (d, 1H), 7.32 (d, 1H), 7.22 (t, 1H), 7.12 (t, 1H), 7.04 (d, 1H), 6.48 (d, 1H) 3.78 (s, 3H); 13C NMR (CDCl3) 6136.7, 128.8, 128.5, 121.5, 120.9, 119.3, 109.2, 100.9, 32.8; MS m/z 131 [M+1]+.
  • EXAMPLE 7
  • 1-Methyl-5-nitroindole
    Figure US20050010055A1-20050113-C00020
  • The title compound is prepared analogously to the previous Examples in about 95% yield: 1H NMR (CDCl3) δ 8.57 (d, 1H), 8.11 (dd, 1H), 7.33 (d, 1H), 7.21 (d, 1H), 6.67 (d, 1H), 3.86 (s, 3H); 13C NMR (CDCl3) 6141.5, 139.4, 132.0, 127.6, 118.2, 117.2, 109.1, 103.8, 33.3; MS m/z 176 [M+1]+.
  • EXAMPLE 8
  • 1-Methyl-2-phenylindole
    Figure US20050010055A1-20050113-C00021
  • The title compound is prepared analogously to the previous Examples in about 97% yield: 1H NMR (CDCl3) δ 7.66 (d, 1H), 7.53-7.35 (m, 6H), 7.25 (dd, 1H), 7.14 (t, 1H), 6.57 (s, 1H), 3.75 (s, 3H); 13C NMR (CDCl3) δ 141.5, 138.3, 132.8, 129.3, 128.5, 127.9, 127.8, 121.6, 120.5, 119.8, 109.6, 101.6, 31.1; MS m/z208 [M+1]+.
  • EXAMPLE 9
  • 1-Benzyl-5-bromoindole
    Figure US20050010055A1-20050113-C00022
  • To a mixture of 5-bromoindole (392 mg, 2.0 mmol), DBC (726 mg, 3.0 mmol) and DABCO (22.4 mg, 0.2 mmol) is added DMA (4 mL). The resulting solution is heated at 135° C. for 24 h. The reaction mixture is cooled to RT and diluted with EtOAc (50 mL) and H2O (50 mL). The two layers are separated and the aqueous layer is back extracted with EtOAc (50 mL). The combined organic layers are washed with brine and dried over anhydrous Na2SO4. The mixture is filtered and concentrated under vacuum. The crude residue is purified with Biotage Flash Chromatography unit on 40s cartridge eluting with hexane:CH2Cl2=19:1 solvent mixture to afford 5-bromo-1-benzylindole (about 451.9 mg, 79%) as a white solid: mp 90° C.; 1H NMR (CDCl3) δ 7.68 (d, 1H), 7.16 (m, 4H), 7.04 (m, 4H), 6.40 (d, 1H), 5.20 (s, 2H); 13C NMR (CDCl3) δ 137.0, 134.9, 130.4, 129.4, 128.8, 127.7, 126.6, 124.5, 123.4, 112.8, 111.1, 101.2, 50.2; MS m/z285.0150 [M+1]+.
  • EXAMPLE 10
  • 1-Benzyl-5-nitroindole
    Figure US20050010055A1-20050113-C00023
  • The title compound is prepared analogously to example 9 in about 90% yield as a white solid: mp 103° C.; 1H NMR (CDCl3) δ 8.45 (d, 1H), 7.91 (dd, 1H), 7.15 (m, 5H), 6.95 (m, 2H), 6.57 (d, 1H), 5.21 (s, 2H); 13C NMR (CDCl3) δ 141.7, 139.0, 136.1, 131.4, 129.0, 128.1, 127.9, 126.7, 118.2, 117.4, 109.6, 104.4, 50.6; MS m/z 252.0892 [M+1]+.
  • EXAMPLE 11
  • 1-Benzylindole
    Figure US20050010055A1-20050113-C00024
  • To a mixture of indole (234 mg, 2.0 mmol), DBC (726 mg, 3.0 mmol), DABCO (67.2 mg, 0.6 mmol) and TBAC (556 mg, 2.0 mmol) is added DMA (4 mL). The resulting solution is heated at 135° C. for 2 h. The reaction mixture is cooled to RT and diluted with EtOAc (50 mL) and H2O (50 mL). The two layers are separated and the aqueous layer is back extracted with EtOAc (50 mL). The combined organic layers are washed with brine and dried over anhydrous Na2SO4. The mixture is filtered and concentrated under vacuum. The crude residue is purified with Biotage Flash Chromatography unit on 40s cartridge eluting with hexane:CH2Cl2=19:1 solvent mixture to afford 1-benzylindole (about 331.2 mg, 80%) as a white solid: mp 43° C.; 1H NMR (CDCl3) δ 7.38 (m, 9H), 6.73 (d, 1H), 5.48 (s, 2H); 13C NMR(CDCl3)δ 137.5, 136.3, 128.7, 128.2, 127.6, 126.7, 121.6, 120.9, 119.5, 109.7, 101.6, 50.0; MS m/z 207.1043 [M+1]+.
  • EXAMPLE 12
  • 1-Benzylcarbazole
    Figure US20050010055A1-20050113-C00025
  • A mixture of carbazole (167 mg, 1.0 mmol), DBC (363 mg, 1.5 mmol), DABCO (33.6 mg, 0.3 mmol) and TBAC (2.0 g) is heated at 135° C. for 1 h. A small sample is taken from the melt, cooled down to RT, and added a mixture of H2O (1 mL) and Et2O (1 mL). The organic layer is separated and Et2O is evaporated. The residue is dissolved into a mixture of H2O:CH3CN=1:1 (1 mL) and subjected to a HPLC analysis on Waters 717 HPLC instrument with Symmetry Shield RP8 3.9×150 mm column eluting with 50:50H2O:CH3CN solvent mixture at 40° C. Chromatogram indicated about 91% conversion to the desired product 1-benzylcarbazole.
  • EXAMPLE 13
  • 1-Benzyl-5-bromoindole
    Figure US20050010055A1-20050113-C00026
  • A mixture of 5-bromoindole (3.92 g, 20 mmol), DBC (14.52 g, 60 mmol), DABCO (224 mg, 2.0 mmol) and TBAC (5.56 g, 20 mmol) is dissolved in CH3CN (80 mL). The resulting solution is subjected to microwave irradiation by passing through (flow rate=20 mL/min) a Milestone ETHOS—CFR continuous-flow reactor, which is preheated at 160° C. under 20 bar pressure. After the first pass (6 min) the reaction mixture is collected and cooled to ambient temperature. The mixture is concentrated under vacuum. The residue is diluted with EtOAc and H2O. The two layers are separated and the aqueous layer is back extracted with EtOAc. The combined organic layers are washed with brine and dried over anhydrous Na2SO4. The mixture is filtered and concentrated under vacuum. The crude residue is purified with Biotage Flash Chromatography unit on 40s cartridge eluting with hexane:CH2Cl2=19:1 solvent mixture to afford 5-bromo-1-benzylindole (about 76% yield) as a white solid: mp 90° C.; 1H NMR, 13C NMR and MS data match the ones reported in Example 9.
  • EXAMPLE 14
  • 1-Benzyl-carbazole
    Figure US20050010055A1-20050113-C00027
  • A mixture of carbazole (3.34 g, 20 mmol), DBC (14.52 g, 60 mmol), DABCO (672 mg, 6.0 mmol) and TBAC (5.56 g, 20 mmol) is dissolved in CH3CN (80 mL). The resulting solution is subjected to microwave irradiation by passing through (flow rate=20 mL/min) a Milestone ETHOS—CFR continuous flow reactor, which is preheated at 160° C. under 20 bar pressure. After the third pass (18 min), the reaction mixture is collected and cooled to RT. The mixture is concentrated under vacuum. The residue is diluted with EtOAc and H2O. The two layers are separated and the aqueous layer is back extracted with EtOAc. The combined organic layers are washed with brine and dried over anhydrous Na2SO4. The mixture is filtered and concentrated under vacuum. The crude residue is purified with Biotage Flash Chromatography unit on 40s cartridge eluting with hexane:CH2Cl2=19:1 solvent mixture and afforded 1-benzylcarbazole (about 76% yield) as a white solid: mp 117° C.; 1H NMR (CDCl3) δ 8.05 (d, 2H), 7.20 (m, 11H), 5.42 (s, 2H); 13C NMR (CDCl3) δ 140.6, 137.1, 128.7, 127.4, 126.4, 125.8, 123.0, 120.3, 119.1, 46.5; MS m/z 257.1202 [M+1]+.

Claims (13)

1. A method for the preparation of indole derivatives of the formula
Figure US20050010055A1-20050113-C00028
wherein X is benzyl; and R1, R2, R3 and R4 are independently hydrogen, halogen, cyano, nitro, hydroxy, optionally substituted alkyl, alkoxy, aralkoxy, carboxy, alkoxycarbonyl, aryl or heteroaryl; or R1 and R2 combined together with the carbon atoms to which they are attached form a fused 6-membered aromatic ring; which method comprises reacting indoles of the formula
Figure US20050010055A1-20050113-C00029
wherein R1, R2, R3 and R4 have meanings as defined for formula I;
in the presence of a catalytic amount of a base at an ambient temperature.
2. The method according to claim 1, wherein the base is 1,4-diazabicyclo[2.2.2]octane.
3. The method according to claim 2, wherein the molar ratio of the base to the compound of formula II initially present in the reaction mixture ranges from 0.01:1 to 0.5:1.
4-14. (cancelled)
15. The method according to claim 1, wherein the molar ratio of the base to the compound of formula II initially present in the reaction mixture ranges from 0.05:1 to 0.35:1.
16. The method according to claim 1, wherein the ambient temperature ranges from 90° C. to 150° C.
17. The method according to claim 1, wherein the reaction is carried out in the presence of an organic solvent.
18. The method according to claim 17, wherein the organic solvent is selected from the group consisting of toluene, acetonitrile, N,N-dimethylformamide, N,N-dimethylacetamide and N-methylpyrrolidinone.
19. The method according to claim 18, wherein the organic solvent is N,N-dimethyl-acetamide.
20. The method according to claim 19, wherein the ambient temperature is 135° C.
21. The method according to claim 1, wherein the reaction is carried out in the presence of an ionic liquid.
22. The method according to claim 21, wherein the ionic liquid is tetra-n-butylammonium chloride.
23. The method according to claim 1, wherein the process is conducted under microwave irradiation at a frequency from 300 MHz to 30 GHz, and at a temperature ranging from 80° C. to 300° C. for a period of microwave irradiation time ranging from 1 second to 300 min.
US10/917,058 2002-07-18 2004-08-12 N-alkylation of indole derivatives Abandoned US20050010055A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/917,058 US20050010055A1 (en) 2002-07-18 2004-08-12 N-alkylation of indole derivatives

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39682702P 2002-07-18 2002-07-18
US10/620,625 US6972336B2 (en) 2002-07-18 2003-07-16 N-alkylation of indole derivatives
US10/917,058 US20050010055A1 (en) 2002-07-18 2004-08-12 N-alkylation of indole derivatives

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/620,625 Division US6972336B2 (en) 2002-07-18 2003-07-16 N-alkylation of indole derivatives

Publications (1)

Publication Number Publication Date
US20050010055A1 true US20050010055A1 (en) 2005-01-13

Family

ID=31997532

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/620,625 Expired - Lifetime US6972336B2 (en) 2002-07-18 2003-07-16 N-alkylation of indole derivatives
US10/917,058 Abandoned US20050010055A1 (en) 2002-07-18 2004-08-12 N-alkylation of indole derivatives
US11/009,206 Expired - Lifetime US7067676B2 (en) 2002-07-18 2004-12-10 N-alkylation of indole derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/620,625 Expired - Lifetime US6972336B2 (en) 2002-07-18 2003-07-16 N-alkylation of indole derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/009,206 Expired - Lifetime US7067676B2 (en) 2002-07-18 2004-12-10 N-alkylation of indole derivatives

Country Status (1)

Country Link
US (3) US6972336B2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7868037B2 (en) * 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP1771169A1 (en) * 2004-07-14 2007-04-11 PTC Therapeutics, Inc. Methods for treating hepatitis c
US7772271B2 (en) * 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) * 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (en) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス,インコーポレーテッド Thienopyridine for treating hepatitis C
MD4233C1 (en) * 2012-03-02 2014-01-31 Институт Химии Академии Наук Молдовы Catalyst for the synthesis of 2-pyrrol-3-iloxindole derivatives
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
JP6064062B2 (en) 2013-03-15 2017-01-18 ファイザー・インク Indazole compounds that activate AMPK
JP7266365B2 (en) 2015-05-26 2023-04-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Novel heteroaromatic silicon fluoride acceptors useful for 18F labeling of molecules and biomolecules and methods for their preparation
DE112018005145T5 (en) 2017-09-15 2020-07-23 The Regents Of The University Of California INHIBITION OF AMINOACYLASE 3 (AA3) IN TREATMENT OF CANCER
CN108727246B (en) * 2018-06-19 2020-01-07 浙江工业大学 Preparation method of substituted indole C3 alkylated derivative
CN109438329A (en) * 2018-12-13 2019-03-08 广东奥美格传导科技股份有限公司 A kind of preparation method for the carbazole that aliphatic hydrocarbon replaces

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596877B2 (en) * 2001-10-17 2003-07-22 Novartis Ag Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326501B1 (en) 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596877B2 (en) * 2001-10-17 2003-07-22 Novartis Ag Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols

Also Published As

Publication number Publication date
US7067676B2 (en) 2006-06-27
US6972336B2 (en) 2005-12-06
US20040059131A1 (en) 2004-03-25
US20050101786A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
US6972336B2 (en) N-alkylation of indole derivatives
RU2383534C2 (en) Enantioselective method for synthesis of quinoline derivatives
US20080114013A1 (en) Spiroindolinone derivatives
Wang et al. Catalytic thiourea promoted electrophilic thiocyanation of indoles and aromatic amines with NCS/NH4SCN
ZA200602694B (en) Process for the preparation of N-amino substituted heterocyclic compounds
CA2716979A1 (en) Spiroindolinone derivatives
IE83508B1 (en) Quinoxalines, processes for their preparation, and their use
Hagan et al. Antitumour polycyclic acridines. Part 1. Synthesis of 7H-pyrido-and 8H-quino-[4, 3, 2-kl] acridines by Graebe–Ullmann thermolysis of 9-(1, 2, 3-triazol-1-yl) acridines: application of differential scanning calorimetry to predict optimum cyclisation conditions
Michman et al. The synthesis of 2, 4 [1H, 3H] quinazolinedione and some of its 3-aryl substituted derivatives
US5256799A (en) Preparation of 6-hydroxyindolines and their use for preparation of novel laser dyes
Nagarathnam A facile synthesis of 3‐substituted indoles
AU2020223101A1 (en) Processes and compounds
Molina et al. Fused carbazoles by tandem Aza Wittig/electrocyclic ring closure. Preparation of 6H-pyrido [4, 3-b] carbazole, 11H-pyrido [4, 3-a] carbazole and 11H-pyrido [3, 4-a] carbazole derivatives
Kapples et al. Synthesis of 1‐alkyl‐2, 3‐dihydro‐2‐(4‐pyridinyl)‐1H‐isoindoles as potential selective serotonin reuptake inhibitors
Nowak et al. Synthesis of new pentacyclic diquinothiazines
Rouden et al. Palladium mediated cross-coupling reaction of an heteroaryl-imidoyl chloride and primary amines—preparation of a new ligand of serotoninergic receptors
Cupps et al. Synthetic strategies for 2, 4-dimethoxypyrrolo [3, 2-d] pyrimidine
JP4700916B2 (en) Method for producing pyridine derivative
Hojati et al. New Mothod for Synthesis of Indole Derivatives via Zirconium (IV) Chloride Catalyst
Karchava et al. Indoles from 3-nitropyridinium salts: A new route to chiral indoles and indolines
Gibson et al. Reissert compound studies. Cyclization of N‐(ω‐chloroalkanoyl) reissert compounds
FI63758C (en) REFRIGERATION FOR FRAMSTAELLNING AV 1- (2-TETRAHYDROFURYL) -5-FLUORURACIL
CN108276419B (en) The synthetic method of a kind of azoles and quinazoline ternary fused heterocyclic derivative
KR20040095332A (en) Method for manufacture of sertindole
El-Shafei et al. Catalytic alkylation, sulphonation, and heteroarylation of some bicyclic pyrazolines in solid-liquid two phase systems.

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE